foxo4 dri human trials results

foxo4 dri human trials results Frontiers Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4 dri human trials results Frontiers Peptide inhibitors targeting FOXO4-p53 interactions
Brand: centoria.fr
SKU: 28258556371
Price: 22.50 USD
Availability: InStock
Rating: 4.769500000000001 (21 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC

SKU: 28258556371 · From centoria.fr

4.8

USD22.50 USD63.50

Pay in 4 interest-free payments of $5.62 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

This rigorous testing verifies exact molecular weights, proper structural salification, and sequence maps while ensuring the total absence of residual synthesis reagents or contaminants

Supplied as a lyophilized powder, it is readily soluble in water

Think of them as advanced tools for when youre ready to take your results to the next level

It belongs to a class of drugs known as multi-receptor agonists, and its mechanism of action is notably broad: it simultaneously activates three hormone receptors the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor